Case study · With iBET and Eppendorf
Hybrid modeling for scalable cardiomyocytes expansion
A cell therapy use case performed with iBET and Eppendorf, comparing a hybrid model against a statistical linear model on hiPSC-derived cardiomyocyte expansion.
-
6
Bioreactor runs were enough to predict full VCD, glucose, lactate and LDH profiles
-
3
Dissolved oxygen conditions distinguished, capturing the non-linear DO effect a linear model missed
-
Optimal feed and DO combination found in silico, maximizing growth while minimizing media
The challenge
Every experiment counts
Cell therapies are resource-intensive, with high material costs and outcomes highly sensitive to oxygen levels and feed rates. Scientists must explore the design space with limited experimental capacity.
The approach
Hybrid versus linear, then simulate
A hybrid model was trained on runs in Eppendorf DASGIP® parallel bioreactors across three DO conditions, compared with a linear model for final-day VCD, and used to simulate feed and DO scenarios.
- 6 bioreactor runs
- 3 DO conditions
- VCD final-day target
Get the full results
Download the full case study, with project outline, analysis, and case results.